Search

Your search keyword '"Lubinski J."' showing total 38 results

Search Constraints

Start Over You searched for: Author "Lubinski J." Remove constraint Author: "Lubinski J." Publisher united kingdom Remove constraint Publisher: united kingdom
38 results on '"Lubinski J."'

Search Results

1. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.

2. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.

3. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.

4. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.

5. Survival from breast cancer in women with a BRCA2 mutation by treatment.

6. Mendelian randomisation study of smoking exposure in relation to breast cancer risk.

7. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.

8. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.

9. Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.

10. Survival from breast cancer in women with a BRCA2 mutation by treatment.

11. Mendelian randomisation study of smoking exposure in relation to breast cancer risk.

12. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.

13. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.

14. Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.

15. Two truncating variants in FANCC and breast cancer risk.

16. Prediction and clinical utility of a contralateral breast cancer risk model.

17. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.

18. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.

19. Two truncating variants in FANCC and breast cancer risk.

20. Prediction and clinical utility of a contralateral breast cancer risk model.

21. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.

22. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.

23. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.

24. Shared heritability and functional enrichment across six solid cancers.

25. Genome-wide association study of germline variants and breast cancer-specific mortality.

26. Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature Communications, (2019), 10, 1, (431), 10.1038/s41467-018-08054-4).

27. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer.

28. Erratum to: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (Nature Communications, (2018), 9, 1, (4616), 10.1038/s41467-018-06863-1).

29. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.

30. Shared heritability and functional enrichment across six solid cancers.

31. Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature Communications, (2019), 10, 1, (431), 10.1038/s41467-018-08054-4).

32. Genome-wide association study of germline variants and breast cancer-specific mortality.

33. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer.

34. Erratum to: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (Nature Communications, (2018), 9, 1, (4616), 10.1038/s41467-018-06863-1).

35. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.

36. Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.

37. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.

38. Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.

Catalog

Books, media, physical & digital resources